Botaniex, Inc. Announces $1.5 M in Financing for Construction of Plant.

HOUSTON -- Botaniex, Inc. (BTXI: Pink Sheets), announced today that it has signed a memorandum of understanding for $1.5 million in financing. The Company anticipates closing the financing within the next few weeks. This financing will be utilized to fund the construction of Botaniex's plant, including the purchase of manufacturing equipment and R&D devices, on the recently acquired 16.5-acre parcel of land in Zhaoqing High Technology Industry Development Zone, Guangdong Province, China. In addition, the Company will employ the financing to fulfill current contracts or orders from its customers as well as to assist in securing contracts that are presently under negotiation.

Botaniex's future plant will be a state-of-the-art facility combining two types of extraction technologies - traditional solvent extraction and super-critical fluid extraction (SCFE). This unique combination will provide Botaniex with a significant competitive advantage in the $19 billion natural products industry. The plant will have an annual capacity of 200 metric tonnes of powdered extracts and 40 metric tonnes of essential oils; generating sales of approximately $7,000,000 per annum. Upon completion of this plant, Botaniex will emerge as a key player in the botanical/herbal extracts industry and enable the Company to compete for and secure large orders from multi-national dietary supplements companies.

Botaniex CEO Melson Liao stated: "We are very pleased to have lined up this favorable new funding. It will allow us to proceed with the construction of our plant as scheduled and to meet the market demand for our products. This financing will not only fund our organic or internal growth but also put us in a stronger position to pursue our merger and acquisition (M&A) growth strategy. In fact, we are now in M&A negotiations with two China-based companies - one is a pharmaceutical firm and the other is in the herbal extracts industry. Further details will be disclosed to shareholders once a letter of intent is signed with either firm."

About Botaniex Inc.

Botaniex Inc. is an innovative manufacturer of botanical/herbal extracts, serving the worldwide manufacturers of dietary supplements, health foods, functional beverage, pharmaceuticals and cosmetics. The Company's product line is broad, ranging from tea and herbal extracts to essential oils. Botaniex not only provides customized ingredients, but also offers value-added services such as formulation assistance, clinical trial support and private label manufacturing. The Company is in the process of expanding its operations, including its client and asset-base, in Asia and overseas. Botaniex's goal is to become a major player in the multi-billion dollar global herbal products industry.

For more information please contact CEO Melson Liao at [e-mail] or visit the Corporate website at www.botaniex.com.

Forward-Looking Statements 

Please be advised that statements made herein, other than historical data, constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. The potential risks and uncertainties include, among others, potential volatility in the company's stock price, increased competition, customer acceptance of new products and services offered by the company, and uncertainty of future revenue and profitability and fluctuations in its quarterly operating results. Please also be advised that the company's stock is not currently registered with the Securities and Exchange Commission.